Skip to content
Screener

Enanta Pharmaceuticals ENTA Q4 2025 earnings

Reported February 9, 2026 · Before market open

Revenue$18.6MBeat by $2.7M
EPS-$0.42Beat by $0.12
Revenue estimate$15.9M
EPS estimate-$0.54

Next report

Nov 16, 2026 (in 2 months)
Revenue estimate$15.7M
EPS estimate-$0.77

FAQ

When did Enanta Pharmaceuticals report Q4 2025 earnings?
Enanta Pharmaceuticals (ENTA) reported Q4 2025 earnings on February 9, 2026 before market open.
What were Enanta Pharmaceuticals's Q4 2025 revenue and EPS?
Enanta Pharmaceuticals reported revenue of $18.6M and eps of $-0.42 for Q4 2025.
Did Enanta Pharmaceuticals beat estimates in Q4 2025?
Revenue beat the consensus estimate of $15.9M by $2.7M. EPS beat the consensus estimate of $-0.54 by $0.12.
How did Enanta Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.8% from $17.0M a year earlier and eps grew 60.0% from $-1.05.
Where can I find Enanta Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-042812) and the 10-Q periodic report (0001193125-26-046502) directly on SEC EDGAR. The filing index links above go to sec.gov.